Table a1 Summary results on efficacy
Event | RT alone | CMT |
|---|---|---|
Locoregional relapse rate (%) at | ||
 3 years | 53.4 | 29.7 |
 5 years | 57.1 | 32.3 |
 10 years | 59.1 | 33.8 |
 12 years | 59.1 | 33.8 |
Relapse-free survival rate (%) at | ||
 3 years | 38.4 | 51.1 |
 5 years | 33.7 | 46.6 |
 10 years | 23.5 | 36.2 |
 12 years | 17.7 | 29.7 |
Colostomy-free survival rate (%) at | ||
 3 years | 40.5 | 50.4 |
 5 years | 36.8 | 46.9 |
 10 years | 25.6 | 35.6 |
 12 years | 20.1 | 29.6 |
Overall survival rate (%) at | ||
 3 years | 60.0 | 64.6 |
 5 years | 53.0 | 58.1 |
 10 years | 35.8 | 41.5 |
 12 years | 27.5 | 33.1 |
Anal cancer death rate (%) at | ||
 3 years | 35.9 | 25.9 |
 5 years | 41.8 | 30.5 |
 10 years | 47.7 | 35.3 |
 12 years | 48.7 | 36.2 |
